All of these findings have contributed to the widespread belief that the levels of miRNAs controls the trajectory of CD8+ T cells, though these studies have mainly focused on their function in tumor and infection models, which are rare in IBD. The gene discussed is CD8A; the disease is inflammatory bowel disease.